Skip to content

There. You're smarter.

  • Articles
  • SmartPill
  • FastPoll
  • HealthyDose
  • Contact Us
  • About InsightCity
  • Search

SmartPill™ for the Week of February 26, 2018

Posted on February 25, 2018February 26, 2018Author 9586wpczarCategories SmartPill™ of the WeekTags biopharma, research, research funding

R&D ROI:

Source: Deloitte

Related

Post navigation

Previous Previous post: FastPoll™ for the Week of February 19, 2018
Next Next post: Marijuana Mythbusting

Sign up for our newsletter

FastPoll™ for the Week of January 14, 2019

Do you know anyone with dementia?

  • FastPoll™ for the Week of January 21, 2019
    Do you know anyone with dementia? […]
  • FastPoll™ for the Week of January 14, 2019
    Which of the following do you believe is the biggest global health concern right now? […]
  • FastPoll™ for the Week of January 7, 2019
    The new US hospital pricing transparency law…what do you think? […]
  • FastPoll™ for the Week of December 31, 2018
    In which of the following aspects of your life do you foresee the biggest improvements in 2019? […]
  • FastPoll™ for the Week of December 24, 2018
    Which of the following best reflects your level of education? […]

Tags

AbbVie addiction adherence advertising Aetna alcohol allergan ALS Alzheimer’s Alzheimer’s disease Amazon Amgen antibiotic resistance antibiotics anxiety Apple apps AstraZeneca bacteria biologics biopharma Biosimilar biosimilars biotech breakthrough therapy breast cancer Brexit California Canada cancer CAR-T CDC Celgene China clinical development clinical research clinical trials coffee CRISPR crowdsourcing CVS data Deloitte dementia depression diabetes diet direct to consumer DOJ drug approvals drug development Drug Pricing DTC education electronic health records Eli Lilly emergency department employment epidemic ethics EU exercise Express Scripts FDA fitness flu food gene editing generics gene therapy genetics Gilead Google Gottlieb GSK health healthcare healthcare costs health insurance heart disease HHS HIV hospitals Humira IBM immunotherapy infection influenza Innovation insulin insurance J&J lawsuits legislation life expectancy M&A malaria manufacturing marijuana marketing Medicaid medical device medical devices Medicare mental health Merck mHealth Mylan NHS NICE NIH Novartis nutrition obesity oncology opioids orphan drugs overdose Parkinson’s disease patents patient recruitment patients PBM pediatrics pfizer pharma pharmacy Phase I PhRMA physician payments physicians preclinical pregnancy prescriptions pricing privacy public health R&D regulation regulatory research right-to-try Roche Sanofi Shkreli side effects sleep sleep deprivation smoking social media stem cells stroke sugar Takeda technology Teva tobacco Trump UK vaccines vaping Watson wearables weight loss WHO youth zika

Sign up for updates

Contact us

info@InsightCity.com | 919-230-6767
Theme: Maisha Lite designed by Anariel Design.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok